The global rheumatology therapeutics market size stood at around USD 44 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Rheumatology is the discipline of internal medicine that involves the diagnosis and treatment of rheumatic diseases. Rheumatic diseases are characterized by the inflammation that affects joints, tendons, ligaments, bones and sometimes organs. Rheumatic diseases are also called as musculoskeletal disease causes severe pain, deformity and morbidity and leads to heavy economic burden due to high cost of treatment.
The global rheumatology therapeutics market is projected to be driven by the increasing geriatric population in developed countries, increase in the number of new drugs approval and growing R&D investments. Rising prevalence of rheumatology diseases are boosting requirement of its treatments which is fuelling growth of the global rheumatology therapeutics market.
Major Rheumatology Disease
The major disease includes rheumatoid arthritis, osteoarthritis, gout, psoriatic arthritis, ankylosing spondylitis and others. Out of the rheumatoid arthritis disease has high prevalence rates than other disease and accounts for the major share in global rheumatology therapeutics market.